RSLS - ReShape Lifesciences Inc.
IEX Last Trade
0.1524
-0.008 -5.446%
Share volume: 699,809
Last Updated: Fri 30 Aug 2024 09:42:54 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$0.16
-0.01
-5.17%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-23 | 2022-08-19 | 2022-11-14 | |
| Cash flow financing | 0.000 | 2.489 M | 3.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -7.378 M | -6.422 M | -5.272 M | |
| Net income | -8.215 M | -9.576 M | -11.811 M | |
| Depreciation | 550.000 K | 545.000 K | 543.000 K | |
| Changes in inventories | 3.998 M | 4.226 M | 4.171 M | |
| Changes in receivables | 2.410 M | 2.448 M | 2.230 M | |
| Investing Cashflow | 2.000 K | 18.000 K | -33.000 K | |
| Net Borrowings | -17.169 M | -12.763 M | -7.072 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -7.000 K | -12.000 K | -33.000 K | |
| Cash Change | 15.410 M | 11.494 M | 6.146 M |